Renaissance Capital logo

Augmedix Scheduled, Nasdaq: AUGX

Provides remote documentation software to the healthcare industry.

Industry: Technology

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Technology

Augmedix was incorporated in 2013 and launched its commercial real-time, remote documentation services in 2014. We provide software that is compatible with off-the-shelf mobile client devices (smartphones or Google Glass) which enables clinicians to communicate with our service platform, overseen by remotely located medical data specialists (each an “MDS”, and collectively “MDSs”). Our MDSs observe the clinician-patient interaction, through an audio/video stream, and extract the relevant elements of that interaction. Those elements are then used by our proprietary Notebuilder tool to automatically create sentences in the appropriate section of the medical note. Once completed, the medical notes are uploaded into the patient’s chart contained within the electronic health record (“EHR”) system. The EHR system is third-party software licensed by the healthcare clinic or system to manage patient charts. Patient care in the United States is provided in ambulatory or clinical environments and hospitals. We focus most of our efforts in the ambulatory/clinical segment of the patient care market. Roughly 85% of the physicians who subscribe to our service are employed directly by, or are affiliated with, a healthcare enterprise. The remaining 15% consists of small practices and individual practitioners.
more less
IPO News for Augmedix
more
IPO Data
IPO File Date 09/03/2021
Offer Price
Price Range $6.00 - $6.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $6.00 - $6.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters San Francisco, CA
Founded 2013
Employees 618
Website www.augmedix.com